Join
Live feed
·
PRReleasevia Quantisnow
Cancer Genetics, Inc. logo
Cellular Biomedicine Group, Inc. logo
Otelco Inc. logo
+6

Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)

ByQuantisnow·Wall Street's wire, on your screen.
CGIX· Cancer Genetics, Inc.CBMG· Cellular Biomedicine Group, Inc.OTEL· Otelco Inc.YIN· Yintech Investment Holdings LimitedVAR· Varian Medical Systems, Inc.AKCA· Akcea Therapeutics, Inc.
Health CarePublic UtilitiesFinance
Full content unavailable. See the original source below.
Original source
Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN) | Quantisnow